Fig. 4From: Impact of intralesional botulinum toxin type A therapy on the keloid-related quality of lifeBar chart showing the comparison between the subscales’ results and the total scores of both groups. V1, the first questionnaire fulfilling (1 week before therapy); V2, the second questionnaire fulfilling (the day of the first injection); V3, the third questionnaire fulfilling (the day of the second injection one; month after the first injection); V4, the fourth questionnaire fulfilling (6 months after the first injection)Back to article page